Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-25 @ 10:56 PM
Study NCT ID:
NCT00398567
Status:
COMPLETED
Last Update Posted:
2018-07-24
First Post:
2006-11-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-04-04
Start Date Type:
ACTUAL
Primary Completion Date:
2009-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-09
First Submit QC Date:
None
Study First Post Date:
2006-11-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-10
Results First Submit QC Date:
None
Results First Post Date:
2018-04-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-03-11
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-06-26
Last Update Post Date:
2018-07-24
Last Update Post Date Type:
ACTUAL